- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01074385
Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making
Use of Dignity Therapy in Stage IV Colorectal Cancer Patients Receiving Chemotherapy to Increase Peaceful Awareness and Impact Goals of Care Decision-Making
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dignity Therapy is a well tolerated structured interview that helps patients reflect on who they are, what is most important to them and what lessons they have learned through life. For patients not receiving chemotherapy, Dignity Therapy gave patients more hope, more meaning in their life, and helped their families. Researchers at Northwestern University would like to see if it has the same effect in patients getting chemotherapy. We will also see if the Dignity Therapy changes patient's understanding of their disease and their medical preferences.
All study procedures will take place when participants come for a scheduled doctor's visit or to receive chemotherapy. At the first visit participants will answer a questionnaire taking approximately 15-30 minutes. Participants will then have a Dignity Therapy Session approximately 1-2 weeks later. A second Dignity Therapy Session will be scheduled again in another 1-2 weeks. Each study Dignity Therapy Session will take approximately an hour. One to two weeks later a repeat questionnaire will be filled out. Finally, a third and final questionnaire will be complete 4 weeks later.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University, Northwestern Memorial Faculty Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
- Participants must be currently receiving treatment for stage IV colorectal cancer.
- Participants must have experience disease progression after their first course of treatment and are being considered for second course of treatment or have already started their second course of treatment.
- Participants must be 18 years old or older.
- All participants must have given signed, informed consent prior to registration on study.
- Participants must speak English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Immediate Dignity Therapy
At registration, subjects will be mailed a questionnaire.
The subject will then receive two separate dignity therapy sessions, about a week apart.
Subjects will then be asked to complete a questionnaire 1-2 weeks after completing therapy sessions and one month after completing therapy sessions.
|
Dignity therapy is a psychotherapeutic intervention developed to address psychosocial and existential distress among terminally ill patients.
Basically, it invites patients to discuss topics that matter most or how they want to be remembered.
This interview is recorded and then edited and returned to the patient to be used for further reflection or for sharing with loved ones.
|
|
OTHER: Wait List Dignity Therapy
At registration, subjects will be mailed a questionnaire.
The subject will then receive two separate dignity therapy sessions; the first session will take place about 6 weeks after registration, with the second session occurring 1-3 weeks after the first.
Subjects will then be asked to complete a questionnaire about one month after completing therapy sessions.
|
Dignity therapy is a psychotherapeutic intervention developed to address psychosocial and existential distress among terminally ill patients.
Basically, it invites patients to discuss topics that matter most or how they want to be remembered.
This interview is recorded and then edited and returned to the patient to be used for further reflection or for sharing with loved ones.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact of Dignity Therapy
Time Frame: at baseline, 1-2 weeks after completion of dignity therapy sessions, 1 month after completion of sessions
|
Measure the impact of dignity therapy on terminal illness acknowledgment and presence of peaceful awareness.
Subjects will complete self-evaluation questionnaires at the point of registration and upon completing dignity therapy sessions.
The impact will be determined by changes in the patient's baseline self-reported parameters.
|
at baseline, 1-2 weeks after completion of dignity therapy sessions, 1 month after completion of sessions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure the impact of dignity therapy on life sustaining therapy and end-of-life goals of care.
Time Frame: at baseline, 1-2 weeks after completion of dignity therapy sessions, 1 month after completion of dignity therapy sessions
|
Subjects will complete self-evaluation questionnaires at the point of registration and upon completing dignity therapy sessions.
The impact will be determined by changes in the patient's baseline self-reported parameters.
|
at baseline, 1-2 weeks after completion of dignity therapy sessions, 1 month after completion of dignity therapy sessions
|
|
Establish a correlation between terminal illness acknowledgement and presence of peaceful awareness with preferences for life sustaining therapy and end-of-life goals of care.
Time Frame: At Study Completion
|
Establish a correlation between terminal illness acknowledgement and presence of peaceful awareness with preferences for life sustaining therapy and end-of-life goals of care.
|
At Study Completion
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Linda Emanuel, MD, PhD, Northwestern University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NU 09CC3
- STU00022908 (OTHER: Northwestern University IRB)
- NCI-2010-01851 (OTHER: NCI CTRP#)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stage IV Colorectal Cancer
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Not yet recruitingColorectal Adenocarcinoma | Stage III Colon Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage IV Colon Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II... and other conditions
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruitingColorectal Cancer | Colorectal Cancer Stage IV | Stage IV Colorectal Cancer Positive for BRAF V600E MutationUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes... and other collaboratorsCompletedUnresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Recurrent Colorectal Carcinoma | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNot yet recruitingBreast Cancer | Colorectal Cancer | Prostate Cancer | Breast Cancer Stage IV | Thyroid Cancer | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Breast Cancer Stage III | Prostate Cancer Stage III | Prostate Cancer Stage IV | Thyroid Cancer Stage IV | Thyroid Cancer Stage IIIUnited States, Mexico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Metastatic Small Intestinal Adenocarcinoma | Stage IV Small Intestinal Adenocarcinoma AJCC v8United States
Clinical Trials on Dignity Therapy
-
University of FloridaM.D. Anderson Cancer Center; National Cancer Institute (NCI); Northwestern University and other collaboratorsCompleted
-
European University of RomeRecruitingDeath | Psychological Distress | Emotional Stress | DignityItaly
-
Azienda Unita Sanitaria Locale Reggio EmiliaCompletedAdvanced Cancer | DignityItaly
-
University of ZurichWaid City Hospital, ZurichCompletedDepressive Disorder | Dementia, MildSwitzerland
-
Mayo ClinicCompletedPancreatic Cancer | Non-Small-Cell Lung CancerUnited States
-
Necmettin Erbakan UniversityCompleted
-
Mayo ClinicCompletedAdvanced CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingEnd of LifeUnited States
-
University of ZurichSwiss Cancer LeagueCompleted
-
University of ManitobaCanadian Institutes of Health Research (CIHR)CompletedPalliative Care | Family | End of Life CareCanada